Dessie Sybil G, Hacker Michele R, Haviland Miriam J, Rosenblatt Peter L
Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA, USA,
Int Urogynecol J. 2015 Jun;26(6):865-73. doi: 10.1007/s00192-014-2607-3. Epub 2015 Jan 17.
There has been increasing media attention regarding transvaginal mesh (TVM). We hypothesized that new urogynecology patients have limited knowledge and negative opinions of TVM.
An anonymous survey was distributed to all new patients presenting to the Mt Auburn Hospital urogynecology practice from 1 November 2012 to 31 January 2013. A total of 146 patients completed the questionnaire. The survey was designed to elicit information on participants' knowledge and opinions about TVM and knowledge about recent FDA safety communications. All statistical tests were two-sided, and P values <0.05 were considered statistically significant.
Analyses were restricted to the 77 women who had either heard of TVM or were unsure if they had heard of TVM. A minority (32.5 %) of these women correctly defined TVM, and 33.8 % had a negative impression of TVM. Respondents obtained their information on TVM from the media (48.1 %), the Internet (24.7 %), family or friends (22.1 %), and health care providers (18.2 %). The majority (71.4 %) agreed that they needed more information about TVM before making any decisions about using it to treat their condition. Nearly one quarter of respondents (23.4 %) agreed that they would not want their doctor to use TVM on them for any reason. When asked about recent FDA communications, 27.3 % of patients correctly responded that the FDA had released a safety communication regarding TVM.
The majority of participants had limited knowledge of TVM; however, only a minority had negative opinions. Given our findings, it is important that providers spend more time during the consent process explaining TVM and its risks and benefits as a treatment option.
经阴道网片(TVM)越来越受到媒体关注。我们假设,新的泌尿妇科患者对TVM了解有限且看法负面。
2012年11月1日至2013年1月31日期间,对奥本山医院泌尿妇科门诊的所有新患者进行了匿名调查。共有146名患者完成了问卷。该调查旨在获取参与者对TVM的了解和看法,以及对美国食品药品监督管理局(FDA)近期安全通报的了解。所有统计检验均为双侧检验,P值<0.05被认为具有统计学意义。
分析仅限于77名听说过TVM或不确定是否听说过TVM的女性。这些女性中少数(32.5%)能正确定义TVM,33.8%对TVM有负面印象。受访者获取TVM信息的来源依次为媒体(48.1%)、互联网(24.7%)、家人或朋友(22.1%)和医疗服务提供者(18.2%)。大多数(71.4%)同意,在决定是否使用TVM治疗病情之前,他们需要更多相关信息。近四分之一的受访者(23.4%)同意,无论出于何种原因,都不希望医生对其使用TVM。当被问及FDA近期的通报时,27.3%的患者正确回答FDA已发布有关TVM的安全通报。
大多数参与者对TVM了解有限;然而,只有少数人持负面看法。鉴于我们的研究结果,医疗服务提供者在告知同意过程中,花更多时间解释TVM及其作为一种治疗选择的风险和益处非常重要。